Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7669600
Reference Type
Journal Article
Title
Adaptive changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine
Author(s)
Fernandez, M; Svenningsson, P; Fredholm, BB
Year
1996
Is Peer Reviewed?
1
Journal
Life Sciences
ISSN:
0024-3205
EISSN:
1879-0631
Volume
58
Issue
9
Page Numbers
769-776
Language
English
PMID
8632724
DOI
10.1016/0024-3205(95)02355-0
Abstract
Changes in brain A1 and A2A receptors and in the corresponding mRNA were studied using quantitative receptor autoradiography and in situ hybridisation. [3H]-DPCPX was used as an antagonist ligand at A1 receptors and [3H]-CGS 21680 as an agonist ligand at A2A receptors. Treatment of rats with the relatively A1 receptor selective adenosine analogue R-PIA (0.3 mg/kg) for 7 days in the presence of the peripherally acting antagonist 8-p-sulfophenyltheophylline (8-PST; 10 mg/kg) caused a decrease in the binding of the A1 receptor ligand, but not in that of the A2A receptor ligand. The effect on A1 receptors was also seen in the presence of 100 microM GTP that decreases agonist binding to insignificant levels. There was no change in either A1 or A2A receptor mRNA. No significant changes were detected following administration of either R-PIA or 8-PST alone. These results thus demonstrate an effect on brain A1 receptors after systemic administration of R-PIA in the presence of a peripherally acting adenosine antagonist, demonstrating that, under these conditions, the agonist reaches receptors in significant amounts.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity